Various Articles and Global Programme Background Documents
Click on the corresponding letter
| A B C D E F G H I J K L M N O P Q R S T U V W XYZ |
A
Advances in vaccine stability monitoring technology
by Stephen E. Zweig ; Vaccine 24 (2006)
Alternative Vaccine Strategies for Hepatitis B in Cambodia
A cost-effectiveness analysis of pre-filled disposable syringes (Uniject) compared to one-dose vials and ten-dose vials
by Naree Chan ; BA Degree thesis, Public Policy Program, Stanford University, June 2006
A Dynamic Model of Poliomyelitis Outbreaks : Lessons from the Past to Help Inform the Future
by Radboud J. Duintjer Tebbens, Mark A. Pallansch, Olen M. Kew, Victor M. Cáceres, Roland W. Sutter and Kimberly M. Thompson ; American Journal of Epidemiology, Vol. 162, No. 4, 2005
An evaluation of infant immunization in Africa: is a transformation in progress? by L Arevshatian, CJ Clements, SK Lwanga, AO Misore, P Ndumbe, JF Seward, P Taylor ; Bulletin of the World Health Organization ; Volume 85, Number 6, June 2007, 421-500
An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine
by Daniel Chandramohan, Abraham Hodgsonb, Paul Colemana, Rita Baiden, Kwaku Asante, Elizabeth Awine, Seth Owusu-Agyei, Dominique Boutriau, Christopher B. Nelson and Brain Greenwood ; Vaccine (in press)
A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries
by Theo Wirkas, Steven Toikilik, Nan Miller, Chris Morgan & C. John Clements ; Vaccine 25 (2007)
B
BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection
by María Patricia Arbelá ez, Kenrad E Nelson and Alvaro Muñoz ; International Journal of Epidemiology, 2000; 29: 1085-1091
Benchmarking Immunization Program Performance in the Africa Region
by Joseph F. Naimoli, Shilpa Challa, Miriam Schneidman, Kees Kostermans and Rashmi Sharma ; The World Bank, May 2005
Annex A
Annex B
Annex C
C
Cervical Cancer, Human Papillomavirus and Vaccination
by Catherine M Lowndes and O. Noel Gill ; Editorial reproduced from the British Medical Journal, Oct. 2005, pp. 915-916
Control and Eradication
by Mark Miller, Scott Barrett, and D. A. Henderson ; in Disease Control Priorities in Developing Countries (2nd Edition), Oxford University Press, New York, 2006
Cost-effectiveness of Hepatitis B and Hib Vaccines : Information for Advocacy
Powerpoint presentation by Rosamund Lewis and Humphrey Karamagi ; EPI Managers’ Meeting, Zanzibar, March 9, 2005
Cost-effectiveness of pneumococcal conjugate vaccination in the prevention
of child mortality: an international economic analysis
by Dr Anushua Sinha MD, Orin Levine PhD, Maria D Knoll PhD, Farzana Muhib MPH and Tracy A Lieu MD ; The Lancet, Volume 369, Number 9559, 03 February 2007.
Current Issues in Global Immunization
by Robert Keegan and Julian Bilous ; Seminars in Pediatric Infectious Diseases, 2004.05.005
D
Decentralization and Public Services : The Case of Immunization
by Peyvand Khaleghian ; World Bank Policy Research Working Paper, no. 2989, March 2003
Development of Vaccine Policy in Japan : Current Issues and Policy Directions
by Hiroki Nakatani, Tadashi Sano and Tsutomu Iuchi ; Japanese Journal of Infectious Diseases, 55, 101-111, 2002
Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination
by Caroline L. Trotter, Nigel J. Gay and W. John Edmunds ; American Journal of Epidemiology, Volume 162, Number 1, 89-100, July 2005
E
Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya
by Angela Oloo Akumu, Mike English, J Anthony G Scott and Ulla K Griffiths ; Bulletin of the World Health Organization, Volume 85, Number 7, July 2007, 501-568
Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
by Sun-Young Kim, Joshua A Salomon and Sue J Goldie ; Bulletin of the World Health Organization, Volume 85, Number 11, November 2007, 821-900
Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003
by Montse Soriano-Gabarró, Laurent Toé, Sylvestre R.M. Tiendrebeogo, Christopher B. Nelson, Moumouni Dabal, Mamoudou H. Djingarey, Brian Plikaytis and Nancy Rosenstein,
(WHO Trivalent Vaccine Impact Assessment Study Group) ; Vaccine (in press)
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
by B Bourdin Trunz, PEM Fine and C Dye ; The Lancet, Volume 367, Number 9517, 08 April 2006
Ensuring access to HPV vaccines through integrated services: a reproductive health perspective
by Amy E Pollack, Miranda Balkin, Lindsay Edouard, Felicity Cutts and Nathalie Broutet ; Bulletin of the World Health Organization, January 2007, 85 (1)
EPI and Accelerated Child Survival
Powerpoint presentation by Juan Ortiz, UNICEF/Zimbabwe and Bob Davis, UNICEF/ESARO at a Workshop on a Framework and Guidelines for Integrating Key Child Survival
Interventions with Immunization Activities, Harare, 2 May 2005
Eradicability Of Hepatitis B : A War Of Attrition Against A Vulnerable Enemy
Powerpoint presentation by Robert Davis, UNICEF/ESARO at "Introduction of new vaccines into the Expanded Programme on Immunisation in Southern
Africa", University of Cape Town / NESI, 13-15 October 2004, Cape Town, South Africa
Eradication of Infectious Diseases : Its Concept, Then and Now
by Isao Arita, John Wickett and Miyuki Nakane ; Japanese Journal of Infectious Diseases, 57, 1-6, 2004
Eradication versus control for poliomyelitis : an economic analysis
by Kimberly M. Thompson and Radboud J. Duintjer Tebbens ; The Lancet, Vol. 369, Issue 9570, 21 April 2007
Eradication versus control : the economics of global infectious diseases policies
by Scott Barrett ; Bulletin of the World Health Organization, September 2004, 82 (9)
Evaluating the impact of the HIV pandemic on measles control and elimination
by Rita F. Helfand, William J. Moss, Rafael Harpaz, Susana Scott and Felicity Cutts ; Bulletin of the World Health Organization, May 2005, 83 (5)
Exploring the time to intervene with a reactive mass immunization campaign in measles epidemics
by R.F. Grais, X. de Radiguès, C. Dubray, F. Fermon and P.J. Guerin ; Epidemiology and Infections, vol. 134, issue 4, August 2006
Exposure to heat and freezing in the vaccine cold chain in Thaïland
by Sirirat Techathawat, Porpit Varinsathien, Aimorn Rasdjarmrearnsook & Piyanit Tharmphornpilas ; Vaccine (2006) In Press
F
Fabrication and analysis of plastic hypodermic needles
by H. Kim and J.S. Colton ; Journal of Medical Engineering & Technology, Vol. 29, No. 4, July/August 2005, 181-186
Freezing temperatures in the vaccine cold chain: A systematic literature review
by Dipika M. Matthias, Joanie Robertson, Michelle M. Garrison, Sophie Newland and Carib Nelson ; Vaccine, Volume 25,
Issue 20, 16 May 2007, Pages 3980-3986
G
Global Eradication of Poliomyelitis and Measles : Another Quiet Revolution
by Ciro De Quadros, Pan-American Health Organization ; Annals of Internal Medicine, 15 July 1997, volume 127, number 2
Global eradication of polio: the case for "finishing the job"
by Chandrakant Lahariya ; Bulletin of the World Health Organization, Volume 85, Number 6, June 2007, 421-500
Global Measles Elimination
by William J. Moss and Diane E. Griffin ; Nature, vol. 4, December 2006
H
Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study (free registration required)
by Dr Lara J Wolfson PhD, Peter M Strebel MBChB, Marta Gacic-Dobo BS, Edward J Hoekstra MD, Jeffrey W McFarland MD and Bradley S Hersh MD, for the Measles Initiative ; The Lancet, Volume 369, Number 9557, 20 January 2007
Hepatitis B : Efficacy of vaccines and effectiveness of vaccination programmes
in Viral Hepatitis, September 2004, volume 13, number 1
Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy
by Lixia Wang, Junhua Li, Haiping Chen, Fangjun Li, Gregory L Armstrong, Carib Nelson, Wenyuan Ze and Craig N Shapiro ; Bulletin of the World Health Organization, Volume 85, Number 9, September 2007, 649-732
HPV Vaccines and Screening in the Prevention of Cervical Cancer
by F.X Bosch, J. Cusick, J.T. Schiller, G.P. Garnett, A. Meheus, E.L. Franco and T.C. Wright ; Vaccine, Volume 24, Supplement 3, 31 August 2006
I
Immunizing the World's Children
by Rebecca Fields and Robert Steinglass ; IMMUNIZATIONbasics; Global Health Link, March-April 2005
Improving birth dose coverage of hepatitis B vaccine
by David B Hipgrave, James E Maynard, & Beverley-Ann Biggs ; Bulletin of the World Health Organization, Volume 84, Number 1, January 2006
Introducing HPV Vaccine in Developing Countries — Key Challenges and Issues
by Jan M. Agosti and Sue J. Goldie ; New England Journal of Medicine, Volume 356:1908-1910, Number 19, May 10, 2007
Investigation into a cluster of infants deaths following immunization : evidence for methanol intoxication
by A. Darwish, C.E. Roth, P. Duclos, S.A. Ohn, A. Nassar, F. Mahoney, R. Vogt and R.R. Arthur ; Vaccine, 20 (2002)
Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa?
by Daniel Chandramohan, Jayne Webster, Lucy Smith, Timothy Awine, Seth Owusu-Agyei and Ilona Carneiro ; Tropical Medicine and International Health, Volume 12, no 6, June 2007
J
K
L
Large-Scale Comparative Analysis of Pertussis Population Dynamics: Periodicity, Synchrony, and Impact of Vaccination
by Hélène Broutin, Jean-François Guégan, Eric Elguero, François Simondon and Bernard Cazelles ; American Journal of Epidemiology, Volume 161, Number 12, 1159-1167, June 2005
Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals
by David H Molyneux and Vinand M Nantulya ; BMJ, 2004;328:1129-1132 (8 May)
M
Maternal and neonatal tetanus
by Martha H Roper, Jos H Vandelaer and François L Gasse ; Published online (www.thelancet.com) September 12, 2007
Measles Still Has a Devastating Impact in Unvaccinated Populations
by William J. Moss ; PLoS Medicine, 2007 vol. 4 (1)
Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso
by Adwoa D. Bentsi-Enchill, Issaka Zongob, Selma Khamassi, Robert Pless, Rigobert Thombianod, Sylvestre Tiéndrebéogo, Christopher B. Nelson and Philippe Duclos ; Vaccine (in press)
Monitoring temperatures in the vaccine cold chain in Bolivia
by Carib Nelson, Paulo Froes, Anne Mie Van Dyck, Jeaneth Chavarría, Enrique Boda, Alberto Coca, Gladys Crespo & Heinz Lima ; Vaccine 25 (2007)
Multidisciplinary Evaluation of the Impact of the 2004 Togo National Integrated Child Health Campaign
by Adam Wolkon, MPH, Jodi Vanden Eng, MS, MPH and M. James Eliades MD, MPH ; February 2005
N
Nationwide Hepatitis B Vaccination Program in Taiwan: Effectiveness in the 20 Years After It Was Launched
by Yin-Chu Chien, Chyi-Feng Jan, Hsu-Sung Kuo and Chien-Jen Chen; Epidemiologic Reviews, Vol. 28, 2006
Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso
by J. Vaugelade, S. Pinchinat, G. Guiella, E. Elguero and F. Simondon; British Medical Journal, 2004 December 4; 329(7478): 1309.
O
OPV Cessation--the Final Step To a "Polio-Free" World
by R. Bruce Aylward, Roland W. Sutter and David L. Heymann ; Science 28 October 2005: Vol. 310. no. 5748, pp. 625 - 626
Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine : A controlled, randomized double-blind study in toddlers on the safety and immunogenicity of
Menjugate®, stored at room temperature for six months
by Ines Schöndorf, Angelika Banzhoff, Uwe Nicolay and Francisco Diaz-Mitoma ; Vaccine 25 (2007), 1175-1182.
P
Pervasive Developmental Disorders in Montreal, Quebec, Canada: Prevalence and Links With Immunizations
by Eric Fombonne, MDa, Rita Zakarian, MEda, Andrew Bennett, PhD, CPsychb, Linyan Meng, MSca and Diane McLean-Heywood, MA ; PEDIATRICS Vol. 118 No. 1 July 2006, pp. e139-e150
Polio Eradication Effort Adds New Weapon to Its Armory
by Leslie Roberts ; 14 January 2005 VOL 307 SCIENCE
Polio Eradication : mobilizing and managing the human resources
by R. Bruce Aylward and Jennifer Linkins ; Bulletin of the World Health Organization, April 2005, 83 (4)
Prevention and Control of Perinatal Hepatitis B Virus Transmission in the WHO European Region
Report of a CDC - UNICEF - VHPB - WHO Symposium, 15-17 March 2006, Istambul, Turkey. In Viral Hepatitis, Volume 15, Number 1, December 2006
Protective efficacy of a monovalent oral type 1 polio virus vaccine : a case-control study
by Nicholas C. Grassly, Jay Wenger, Sunita Durrani, Sunil Bahl, Jagadish M. Deshpande, Roland W. Sutter, David L. Heymann and R. Bruce Aylward ; The Lancet Vol. 369, Issue 9570, 21 April 2007, Pages 1356-1362
Public-health impact of accelerated measles control in the WHO African Region 2000–03
by M Otten, R Kezaala, A Fall, B Masresha, R Martin, L Cairns, R Eggers, R Biellik, M Grabowsky, P Strebel, J-M Okwo-Bele and D Nshimirimana ; The Lancet, Volume 366, Number 9488, 03 September 2005
Public-Private Partnership to Develop an Affordable Vaccine for an Emergent Threat : The Trivalent Neisseria meningitidis ACW135 Polysaccharide Vaccine
by Christopher B. Nelson, Maureen Birmingham, Alejandro Costa, Joëlle Daviaud, William Perea, Marie-Paule Kieny and Daniel Tarantola ; American Journal of Public Health, Vol. 97, No. S1, 2007
Q
R
Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba
by The Cuba IPV Study Collaborative Group ; New England Journal of Medicine, Volume 356:1536-1544, Number 15, April 12, 2007
Regulatory pathways for vaccines for developing countries
by Julie Milstien and Lahouari Belgharbi ; Bulletin of the World Health Organization. 2004, 82 (2): 128-133.
Relationship between vaccine vial monitors and cold chain infrastructure in a rural district of India
by Y. Samant, H. Lanjewar, L. Block, D. Parker, B. Stein and G. Tomar ; Rural and Remote Health 7: 617 (Online) 2007.
Rotavirus Vaccines
Presentation by Duncan Steele (WHO) and Robin Biellik (PATH) at the Eastern & Southern African GAVI Regional Working Group, 4-5 October 2005, Harare, Zimbabwe
Rural immunization strategies in Nkwanta District, Ghana : Do Community-based Health Planning and Services improve the chances of complete child immunization?
by John Koku Awoonor-Williams, Maya Vaughan-Smith, James F. Phillips and Frank Nyonator ; Paper presented at the American Public Health Association meeting, December 10-14, 2005, Philadelphia, PA, USA
S
Sabin Monovalent Oral Polio Vaccines : Review of Past Experiences and Their Potential Use after Polio Eradication
by Victor M. Cáceres and Roland W. Sutter; CID 2001:33 (15 August).
Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia
by Abraham Aseffa, Ahmed Bedru , Lawrence Yamuaha, Demis Arga, Alemayehu Worku, Daniel Chandramohan, Christopher B. Nelson, Howard D. Engers ; Vaccine (in press)
Strengthening Immunization in a West African Country: Mali
by Milstien JB, Tapia M, Sow SO, Keita L, Kotloff K ; Education for Health 7 (online), 120, 2007
Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies
by Mark Grabowsky, Theresa Nobiya and Joel Selanikio ; Tropical Medicine and International Health, Volume 12, No. 7, July 2007
T
The Ethics and Politics of Compulsory HPV Vaccination
by James Colgrove ; New England Journal of Medicine, 355;23, December 7, 2006
The Immunization Data Quality Audit : Verifying the Quality and Consistency of Immunization Monitoring Systems
by O.Ronveaux, D. Rickert, S. Hadler, H. Groom, J. Lloyd, A. Bchir & M. Birmingham ; Bulletin of the World Health Organization, July 2005, 83 (7)
The impact of routine infant immunization with Hæmophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence
by Paul Daza, Richard Banda, Keystoxe Misoya, Agnes Katsulukuta, Bradford D. Gessner, Reggis Katsande, Bekithemba R. Mhlanga, Judith E. Mueller, Christopher B. Nelson, Amos Phiri, Elizabeth M. Molyneux and Malcolm M. Molyneux ;
in press, Vaccines, 2006, Elsevier Ltd.
The Meningitis Vaccine Project
by F. Mark Laforce, Kader Konde, Simonetta Viviani and Marie-Pierre Préziosi ; Vaccine (in press)
The promise of conjugate vaccines for Africa
by Marie Paule Kieny and F. Mark Laforce ; Vaccine (in press)
The Role of Measles Elimination in Development of a National Immunization Program
by Walter A. Orenstein ; The Pediatric Infectous Disease Journal, Volume 25, Number 12, December 2006
The State of Routine Immunization Services in Nigeria and Reasons for Current Problems
by Anthony Battersby et al., FBA Health Systems Analysts, June 2005
The Value of Vaccination
by David E. Bloom, David Canning & Mark Weston ; World Economics • Vol. 6 • No. 3 • July–September 2005
Too Hot, Too Cold : Issues With Vaccine Storage
by Larry K. Pickering, Gregory Wallace & Lance Rodewald ; Pediatrics, 2006 Oct : 118 (4), 1738-9
U
Unacceptably High Mortality Related to Measles Epidemics in Niger, Nigeria, and Chad
by R. F. Grais, C. Dubray, S. Gerst, J. P. Guthmann, A. Djibo, K. D. Nargaye, J. Coker, K. P. Alberti, A. Cochet, C. Ihekweazu, N. Nathan, L. Payne, K. Porten,
D. Sauvageot, B. Schimmer, F. Fermon, M. E. Burny, B. S. Hersh, P. J. Guerin ;
PLoS Medicine, 2007 vol.4 (1)
V
Validity of reported vaccination coverage in 45 countries
by Christopher JL Murray MD, Dr Bakhuti Shengelia MPH, Neeru Gupta PhD, Saba Moussavi MPH, Ajay Tandon PhD and Michel Thieren ; The Lancet, Volume 362, Number 9389, 27 September 2003
Virus perpetuation in populations : biological variables that determine persistence or eradication
by N. Nathanson ; Archives of Virology (2005) [Suppl] 00: 1–13
W
When Is a Disease Eradicable? 100 Years of Lessons Learned
by Bruce Aylward, Karen A. Hennessey, Nevio Zagaria, Jean-Marc Olivé and Stephen Cochi ; American Journal of Public Health, October 2000, Vol. 90, No. 10
WHO is to Change its Polio Programme in India to try to eradicate the disease
by Claire Frauenfelder ; British Medical Journal, 2006;333:1089 (25 November)
XYZ